Neither peptide has received regulatory approval as a therapeutic agent from the FDA, EMA, or other major regulatory bodies
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Hassannia, B., Vandenabeele, P
Key Technique: Interlaminar Injection Needle inserted between vertebral laminae Accesses the epidural space Medication spreads across a wider region This differs from targeted injections, as it treats multiple nerve levels simultaneously
Add 3.0 mL bacteriostatic water to the single 10 mg blend vial ~3.33 mg/mL total peptide (about 1.67 mg/mL of each)